Tools
Back to Results

Bichchau Michelle Nguyen, MD, MPH


Overview

Programs + Specialties
Research Interests Clinical guidelines in melanoma and non-melanoma skin cancers, management of high-risk non-melanoma skin cancers, utilization and cost- effectiveness of treatments for skin cancers, healthcare delivery redesign for specialty services, clinical process and outcome measures for skin cancers, quality improvement and patient-centered care
Training + Education Stanford University School of Medicine; University of California- San Diego; Brigham & Women’s Hospital; Harvard School of Public Health
Board Certifications Dermatology
NPI # 1366699381
Gender Female
Language(s) Vietnamese

Locations + Directions

Tufts Medical Center
Biewend Building, 13th Floor
800 Washington St.
Box 114
Boston, MA 02111
Fax #: 617-636-8316
Phone #: 617-636-0156

Honors + Awards

Dermatology Foundation Patient Directed Research Grant
Women’s Dermatologic Society Academic Research Award
Howard Hughes Medical Research Training Fellowship
Stanford University School of Medicine Medical Scholar Research Grant
National Institute of Mental Health Research Training Fellowship
Summa Cum Laude- Economics, University of California-Irvine
Magna Cum Laude- Neurobiology, University of California-Irvine
Economics Departmental Award, University of California-Irvine
University of California- Irvine Undergraduate Research Editorial Board
Phi Beta Kappa

Publications + National Presentations

1. Nguyen BT, Schmults CD. “Preoperative evaluations” in Procedural Dermatology, Matthew Avram, Mark Avram, and Desiree Ratner, Eds. (completed, under contract with McGraw Hill Publishing, 2014)

2. Nguyen BT, Schmults CD. Update on Evaluation and Management of High Risk Squamous Cell Carcinomas. (invited, Current Dermatology Reports, 2014)

3. Eberlin KR, Nguyen B, Karia PS, Carter JB, Liang CA, Schmults CD.The Z-advancement flap for reconstruction of lateral nasal tip and medial alar defects. Dermatol Surg. 2014.

4. Goldenberg A, Nguyen BT, Jiang SI. Knowledge, Understanding and Utilization of Preventive Strategies against Nonmelanoma Skin Cancer in Healthy and Immunosuppressed Mohs Surgery Patients. Dermatol Surg. 2014

5. Nguyen BT, Lortscher DN, Lee RA. “Multiple poromas in a bone marrow transplant recipient: A case report.” Dermatol Online J. 2012 Jul 15;18(7):9.

6. Cannella AP, Nguyen BT, Piggott CD, Lee RA, Vinetz JM, Mehta SR A cluster of cutaneous leishmaniasis associated with human smuggling. Am J Trop Med Hyg. 2011 Jun;84(6):847-50

7. Beaudry VG, Ihrie RA, Jacobs SB, Nguyen BT, Pathak N, Park E, Attardi LD. “Loss of the desmosomal component perp impairs wound healing in vivo”. Dermatol Res Pract. 2010; 2010:759731. Epub 2010 Jun 23.

8. Nguyen BT, Dusek RL, Beaudry VG, Marinkovich MP, Attardi LD. “Loss of desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris auto-antibodies” J Invest Dermatol. 2009 Jul;129(7):1710-8.

9. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD. “Perp is a p63-regulated gene essential for epithelial integrity”. Cell. 2005 Mar 25;120(6):843-56.

Biography

I am a Board certified dermatologist and fellowship trained Mohs micrographic and dermatologic surgeon who specializes in the surgical and non-surgical management of high-risk skin cancers and skin cancers in immunosuppressed patients. I completed my medical school at Stanford University School of Medicine, residency at University of California-San Diego, fellowship at Brigham & Women’s Hospital, and Master of Public Health at the Harvard School of Public Health.

I grew up in Vietnam until the age of 12 when my family immigrated to the United States. We have lived in various towns in California, New York, Maryland, and Washington since then. I still speak Vietnamese, though not as well as I’d like, and like to practice with my patients whenever possible.

My professional goal is to provide timely, patient-centered and effective care for patients with skin cancers, particularly those with difficult to manage tumors, multiple tumors or high-risk of developing new tumors in the future. I want to contribute to the redesign of our healthcare system to improve access to care, efficiency of care delivery and clinical outcomes for our patients. My personal goal is live life to its fullest potential and be happy with myself and my family.